Evidence map›Paper›PMID 28696258›Full record

ArticleThe Journal of biological chemistry2017

Effects of DNA end configuration on XRCC4-DNA ligase IV and its stimulation of Artemis activity.

Christina A Gerodimos, Howard H Y Chang, Go Watanabe, Michael R Lieber

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. TheThe Journal of international medical research · 2020
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Structure and Function of SNM1 Family Nucleases.Advances in experimental medicine and biology · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. NovelFrontiers in pediatrics · 2022
    Article
  11. Article
  12. Review
  13. Review
  14. Mutagenic Consequences of Sublethal Cell Death Signaling.International journal of molecular sciences · 2021
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Christina A GerodimosFrom the Departments of Pathology, Biochemistry & Molecular Biology, and Molecular Microbiology & Immunology and the Department of Biological Sciences, Section of Molecular & Computational Biology, Norris Comprehensive Cancer Center, University of Southern California Keck School of Medicine, Los Angeles, California 90033.
Howard H Y ChangFrom the Departments of Pathology, Biochemistry & Molecular Biology, and Molecular Microbiology & Immunology and the Department of Biological Sciences, Section of Molecular & Computational Biology, Norris Comprehensive Cancer Center, University of Southern California Keck School of Medicine, Los Angeles, California 90033.
Go WatanabeFrom the Departments of Pathology, Biochemistry & Molecular Biology, and Molecular Microbiology & Immunology and the Department of Biological Sciences, Section of Molecular & Computational Biology, Norris Comprehensive Cancer Center, University of Southern California Keck School of Medicine, Los Angeles, California 90033.
Michael R LieberFrom the Departments of Pathology, Biochemistry & Molecular Biology, and Molecular Microbiology & Immunology and the Department of Biological Sciences, Section of Molecular & Computational Biology, Norris Comprehensive Cancer Center, University of Southern California Keck School of Medicine, Los Angeles, California 90033. Electronic address: lieber@usc.edu.
University of Southern California · US

Funding

MECHANISM AND REGULATION OF NONHOMOLOGOUS DNA ENDJOININGR01CA100504 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LIEBER, MICHAEL R · 2003 to 2021
$5.0M
Site-Specific Recombination in Human Health & DiseaseR35GM118009 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LIEBER, MICHAEL R · 2016 to 2025
$4.4M
Mechanisms of Human Lymphoid Chromosomal TranslocationR01CA196671 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LIEBER, MICHAEL R · 2016 to 2021
$1.9M
NCI NIH HHS R01 CA100504NCI NIH HHS R01 CA196671NIGMS NIH HHS R35 GM118009
6 · The paper itself

Abstract

In humans, nonhomologous DNA end-joining (NHEJ) is the major pathway by which DNA double-strand breaks are repaired. Recognition of each broken DNA end by the DNA repair protein Ku is the first step in NHEJ, followed by the iterative binding of nucleases, DNA polymerases, and the XRCC4-DNA ligase IV (X4-LIV) complex in an order influenced by the configuration of the two DNA ends at the break site. The endonuclease Artemis improves joining efficiency by functioning in a complex with DNA-dependent protein kinase, catalytic subunit (DNA-PKcs) that carries out endonucleolytic cleavage of 5' and 3' overhangs. Previously, we observed that X4-LIV alone can stimulate Artemis activity on 3' overhangs, but this DNA-PKcs-independent endonuclease activity of Artemis awaited confirmation. Here, using

Indexed as

Models, MolecularRecombinational DNA RepairV(D)J RecombinationAnimalsCell LineDNADNA-Activated Protein KinaseDNA-Binding ProteinsDNA Breaks, Double-StrandedDNA End-Joining RepairDNA Ligase ATPEndonucleasesHeLa CellsHumansKineticsMothsDCLRE1C protein, humanDNADNA-Activated Protein KinaseDNA-Binding ProteinsDNA Ligase ATPEndonucleasesLIG4 protein, humanNuclear ProteinsPRKDC protein, humanRecombinant Fusion ProteinsRecombinant ProteinsXRCC4 protein, humanantibodyDNA-dependent serine/threonine protein kinase (DNA-PK)DNA recombinationDNA repairdouble strand DNA breaksendonucleaseNHEJnonhomologous DNA end joiningnucleic acid enzymologyV(D)J recombination

Identifiers

PMID28696258
PMCPMC5572927
OpenAlexW2735501845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.